IRIS - Res&Arch Institutional Research Information System - Research & Archive

PIERINI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.307
AS - Asia 2.055
EU - Europa 1.848
SA - Sud America 427
Continente sconosciuto - Info sul continente non disponibili 227
AF - Africa 57
OC - Oceania 4
Totale 7.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.174
SG - Singapore 974
IT - Italia 555
CN - Cina 349
BR - Brasile 318
IE - Irlanda 294
RU - Federazione Russa 247
HK - Hong Kong 234
VN - Vietnam 158
FR - Francia 138
DE - Germania 133
FI - Finlandia 110
KR - Corea 74
GB - Regno Unito 73
CA - Canada 60
SE - Svezia 57
IN - India 54
UA - Ucraina 50
BD - Bangladesh 48
AT - Austria 46
TR - Turchia 33
AR - Argentina 32
MX - Messico 27
PL - Polonia 26
EC - Ecuador 24
NL - Olanda 23
CZ - Repubblica Ceca 19
IQ - Iraq 18
PK - Pakistan 17
ZA - Sudafrica 16
CO - Colombia 15
SA - Arabia Saudita 15
BE - Belgio 14
CH - Svizzera 14
ID - Indonesia 12
VE - Venezuela 12
CR - Costa Rica 11
JP - Giappone 11
PH - Filippine 9
MA - Marocco 8
RO - Romania 8
ES - Italia 7
HN - Honduras 7
LT - Lituania 7
MY - Malesia 7
CL - Cile 6
KE - Kenya 6
NI - Nicaragua 6
PE - Perù 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
PT - Portogallo 5
UZ - Uzbekistan 5
BO - Bolivia 4
DK - Danimarca 4
LB - Libano 4
NP - Nepal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
OM - Oman 3
PY - Paraguay 3
SC - Seychelles 3
SV - El Salvador 3
TN - Tunisia 3
EG - Egitto 2
GF - Guiana Francese 2
KG - Kirghizistan 2
NG - Nigeria 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
KI - Kiribati 1
LC - Santa Lucia 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
Totale 7.691
Salva come PNG Salva come JPEG
Città #
Singapore 719
San Jose 367
Dublin 294
Ashburn 282
Chandler 253
San Mateo 240
Hong Kong 229
Perugia 183
Boardman 165
Santa Clara 130
Council Bluffs 113
Moscow 97
Los Angeles 80
Beijing 79
Lauterbourg 76
Altamura 75
Seoul 74
Munich 64
Andover 60
Medford 59
Princeton 59
New York 57
Lawrence 55
Wilmington 54
Turku 51
Hanoi 45
Ho Chi Minh City 45
Dallas 43
Ann Arbor 38
Vienna 36
São Paulo 32
Piscataway 30
The Dalles 30
Milan 29
Rome 29
Frankfurt am Main 26
Helsinki 26
Phoenix 23
Des Moines 22
London 21
Redmond 20
San Paolo di Civitate 20
Bologna 19
Denver 19
Jacksonville 19
Nuremberg 19
Houston 18
Brooklyn 17
Atlanta 16
Orem 16
Warsaw 16
Hefei 15
North Bergen 15
Norwalk 15
Dearborn 14
Toronto 14
Chicago 13
Falls Church 13
Florence 13
Rio de Janeiro 13
Brno 12
Brussels 12
Johannesburg 12
Boston 11
Montreal 11
Saint Petersburg 11
Amsterdam 10
Quito 10
San José 10
Stockholm 10
Tokyo 10
Hải Dương 9
Lappeenranta 9
Terni 9
Baghdad 8
Charlotte 8
Groningen 8
Guangzhou 8
Manchester 8
Redwood City 8
Riyadh 8
West Jordan 8
Brasília 7
Bucharest 7
Buffalo 7
Da Nang 7
Falkenstein 7
Izmir 7
Marsciano 7
Poplar 7
San Francisco 7
Chennai 6
Foligno 6
Lima 6
Managua 6
Medellín 6
Mexico City 6
Nairobi 6
New Orleans 6
Padova 6
Totale 5.041
Salva come PNG Salva come JPEG
Nome #
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 154
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 152
"Designed" grafts for HLA-haploidentical stem cell transplantation. 133
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 131
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 130
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 129
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 128
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 128
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 127
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 126
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 126
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 123
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 121
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 121
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 120
T regulatory cell separation for clinical application. 117
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 114
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 112
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 111
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 108
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 107
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 106
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 105
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 104
T cells expressing chimeric antigen receptor promote immune tolerance 103
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 103
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 102
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 102
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 102
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 101
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 101
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 100
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 97
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 96
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 95
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 94
New mechanism of lymphoma-induced bone marrow aplasia 94
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 92
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 91
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 89
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 89
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 88
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 87
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 86
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 82
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 82
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 81
Chronic stimulation results in NK cell function impairment mediated by NKG2D 80
The Evolution of T Cell Depleted Haploidentical Transplantation 80
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 80
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 78
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 78
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 77
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 77
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 77
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 77
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 76
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 74
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 73
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 73
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 73
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 70
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 70
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 70
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 69
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 67
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 66
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 66
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 66
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 64
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 63
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 62
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 62
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 61
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 60
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 58
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 58
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 56
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 55
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 54
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 52
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 50
TIM-1 blockade of the donor graft provides protection against lethal GVHD 50
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 49
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 44
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 43
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 43
Role of donor regulatory T cell adoptive immunotherapy in B cell immunity after hematopoietic cell transplantation 39
null 34
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality 29
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 28
CPX-351 Induces High Rate of Complete Remission in the New ICC/ELN 2022 Adverse-Risk Entity ‘AML with MDS-Related Gene Mutations’: Evidence from a Large Real-World Italian Study 27
null 27
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone 20
Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia 18
CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT 12
Totale 7.925
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 0 0 0 15 29 7 10 175 11 25 101 72
2022/2023947 63 212 12 53 62 91 5 39 335 11 48 16
2023/2024584 15 59 14 14 2 14 118 8 41 26 127 146
2024/20251.339 41 126 49 59 176 86 72 101 237 77 196 119
2025/20263.007 220 215 157 404 403 251 520 167 286 265 76 43
2026/2027816 57 115 195 449 0 0 0 0 0 0 0 0
Totale 7.925